Primary experimental recordPositive observation

PMC11279943::ACT006217

PEP2

Evidence text

Paper-level observation

Section 2.2: 'Only one combination yielded a synergistic effect, which was at 12.5 μM P10 and 3.125 μM indolicidin' against MRSA. Section 2.4: 'the combination of 3.125 μM indolicidin and 12.5 μM P10 yielded a synergistic effect against MRSA'

textConfidence: medium

Assay observation

Activity

Antimicrobial

Subtype

Antibacterial

Measure

MIC

Comparator

unknown

Raw observation

in combination with P10 12.5 μM; 3.125 μM

Normalized measurement

unknown3.125 µM

Value minimum

Not reported by source

Value maximum

Not reported by source

Target

Staphylococcus aureus

Assay method

Not reported by source

Sequence

ILPWKWPWWPWRR

Standardization

ready simple

Source publication

Antimicrobial Peptide Screening for Designing Custom Bactericidal Hydrogels.

Pharmaceutics · 2024

DOI 10.3390/pharmaceutics16070860 PMC11279943

Parent mention Integrated peptide

Related peptide identities

PEPDIA-PLP-003672 PEPDIA-INT-078248

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.